The combination of encorafenib and binimetinib for the treatment of patients with BRAF-mutated advanced, unresectable, or metastatic melanoma: an update
2021
Introduction: In the treatment of advanced BRAF-mutated melanoma, selective regulation of the MAPK pathway with BRAF and MEK inhibition has emerged as one of the mainstays of therapy. Areas covered...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
66
References
1
Citations
NaN
KQI